Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-26 @ 1:26 AM
NCT ID:
NCT01412333
Group ID:
EG003
Title:
Ocrelizumab + Interferon Beta-1a Placebo (Double Blind) Ocrelizumab (Open Label)
Description:
In DB phase participants received Ocrelizumab + Interferon Beta-1a Placebo. During the OLE phase, all participants received ocrelizumab 600-mg IV infusion every 24 weeks.
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
121
Serious Number At Risk:
350
Other Number Affected:
317
Other Number At Risk:
350
Study:
NCT01412333
Results Section:
NCT01412333
Adverse Events Module:
NCT01412333